Notice NOT-TR-20-010 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-20-021 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement is to solicit applications for the Vaccine and Treatment Evaluation Units (VTEUs) to implement clinical site protocols (clinical research, clinical trials) for evaluating vaccines, other preventive biologics, therapeutics, diagnostics, including prognostic and predictive markers, and devices for the treatment and prevention of infectious diseases as part of NIAID Infectious Diseases Clinical Research Consortium (IDCRC). A companion FOA solicits applications for the Leadership Group for the Infectious Diseases Clinical Research Consortium, hereafter referred to as the Leadership Group (LG), which provides for overall administrative and scientific leadership for the clinical research and clinical trials conducted. While the primary scientific focus will be on product evaluation for NIAID priority areas, including malaria/neglected tropical diseases, sexually transmitted infections, respiratory infections, and enteric diseases, the VTEUs must also provide surge capacity to address emerging infectious diseases

Notice NOT-LM-20-006 from the NIH Guide for Grants and Contracts

Notice NOT-DE-20-012 from the NIH Guide for Grants and Contracts

Competitive: Vienna BioCenter: The Vienna BioCenter is one of Europe’s leading life science research centres. Vienna (AT)

ARCC is instrumental to UW’s research and academic mission, including UW’s Engineering Initiative, Science Initiative, Data Science Center, NIH’s INBRE…
From University of Wyoming - Wed, 19 Feb 2020 02:14:57 GMT - View all Laramie, WY jobs

The job also expects that the candidate devote 50% of time to contribute to team science across the university for collaborative research through genomic data…
From West Virginia University - Tue, 18 Feb 2020 22:08:37 GMT - View all Morgantown, WV jobs

Notice NOT-DE-20-011 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-114 from the NIH Guide for Grants and Contracts. The High-End Instrumentation (HEI) Grant program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of high-end, specialized, commercially available instruments or integrated systems. The minimum award is $600,001. There is no maximum price limit for the instrument; however, the maximum award is $2,000,000. Types of instruments supported include, but are not limited to: X-ray diffractometers, mass spectrometers, nuclear magnetic resonance (NMR) spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, cell sorters, high throughput robotic screening systems, and biomedical imagers.

Funding Opportunity PAR-20-112 from the NIH Guide for Grants and Contracts. The Shared Instrumentation for Animal Research (SIFAR) Grant Program encourages applications from groups of NIH-funded investigators to purchase or upgrade scientific instruments necessary to carry out animal experiments in all areas of biomedical research supported by the NIH. Applicants may request clusters of commercially available instruments configured as specialized integrated systems or as series of instruments to support a thematic well-defined area of research using animals or related materials. Priority will be given to uniquely configured systems to support innovative and potentially transformative investigations. This FOA supports requests for state-of-the art commercially available technologies needed for NIH-funded research using any vertebrate and invertebrate animal species. This funding opportunity announcement (FOA) does not support requests for single instruments. At least one item of the requested instrumentation must cost at least $50,000, after all applicable discounts. No instrument in a cluster can cost less than $20,000, after all applicable discounts. There is no maximum price requirement; however, the maximum award is $750,000.

Funding Opportunity PAR-20-113 from the NIH Guide for Grants and Contracts. The Shared Instrument Grant (SIG) Program encourages applications from groups of NIH-supported investigators to purchase or upgrade a single item of expensive, specialized, commercially available instruments or integrated systems. The minimum award is $50,000 of direct costs. There is no maximum price limit for the instrument; however, the maximum award is $600,000 of direct costs. Types of instruments supported include, but are not limited to: X-ray diffractometers, mass spectrometers, nuclear magnetic resonance, spectrometers, DNA and protein sequencers, biosensors, electron and light microscopes, cell sorters, and biomedical imagers.

Funding Opportunity RFA-GM-20-001 from the NIH Guide for Grants and Contracts. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on developing courses for skills development - specifically, exportable training modules designed to enhance the rigor, reproducibility, and responsible conduct of biomedical data science research, targeted to trainees and researchers at any career level.

Notice NOT-GM-20-015 from the NIH Guide for Grants and Contracts

Notice NOT-TR-20-007 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-059 from the NIH Guide for Grants and Contracts

Notice NOT-DE-20-001 from the NIH Guide for Grants and Contracts

Notice NOT-DE-20-013 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-21-015 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to establish a network to identify, evaluate, track, and conduct research across multiple sites on older adults with superior cognitive performance for their age ("cognitive super agers"). The activity would support aggregation of sufficient numbers of these individuals to advance the fields understanding of factors that promote sustained cognitive health and those that are not of primary importance. Uniform identification and uniform data collection will allow the study of the behavioral, neurological, health, genetic, environmental, and lifestyle profiles that lead to sustained cognitive and brain function in advanced age. Where extant data exists, harmonization protocols would need to be developed in order to make use of all currently available data. Provision of protocols to obtain brain tissue at autopsy would be an important component.

Funding Opportunity RFA-AG-21-013 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications to develop a multisite, longitudinal, prospective study of idiopathic REM sleep behavior disorder (iRBD) as a prodromal phase of ?-synuclein neurodegenerative disorders.

Notice NOT-MH-20-031 from the NIH Guide for Grants and Contracts